Runfeng Li

2.0k total citations · 1 hit paper
47 papers, 1.4k citations indexed

About

Runfeng Li is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Runfeng Li has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 13 papers in Immunology and 12 papers in Infectious Diseases. Recurrent topics in Runfeng Li's work include Influenza Virus Research Studies (16 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Respiratory viral infections research (7 papers). Runfeng Li is often cited by papers focused on Influenza Virus Research Studies (16 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Respiratory viral infections research (7 papers). Runfeng Li collaborates with scholars based in China, Macao and Hong Kong. Runfeng Li's co-authors include Zifeng Yang, Haiming Jiang, Jin Zhao, Jun Dai, Kui Zheng, Jicheng Huang, Chufang Li, Weiqi Pan, Yongxia Shi and Qinhai Ma and has published in prestigious journals such as Journal of Virology, Chemical Engineering Journal and Journal of Medicinal Chemistry.

In The Last Decade

Runfeng Li

44 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)

2020 495 citations Runfeng Li, Yunlong Hou et al. Pharmacological Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Runfeng Li China	16	509	392	326	303	216	47	1.4k
Haiming Jiang China	19	413 0.8×	510 1.3×	299 0.9×	260 0.9×	176 0.8×	50	1.5k
Chufang Li China	21	567 1.1×	557 1.4×	225 0.7×	212 0.7×	470 2.2×	45	1.7k
Jia-Tsrong Jan Taiwan	10	600 1.2×	472 1.2×	261 0.8×	223 0.7×	139 0.6×	11	1.5k
Young-Hee Jin South Korea	22	373 0.7×	405 1.0×	169 0.5×	114 0.4×	225 1.0×	82	1.5k
Su‐Hua Huang Taiwan	20	330 0.6×	547 1.4×	168 0.5×	151 0.5×	110 0.5×	29	1.6k
Gabriele Bauer Germany	8	891 1.8×	337 0.9×	523 1.6×	238 0.8×	135 0.6×	9	1.9k
Hyung‐Jun Kwon South Korea	21	522 1.0×	537 1.4×	199 0.6×	127 0.4×	123 0.6×	59	1.5k
Yongxia Shi China	11	338 0.7×	358 0.9×	205 0.6×	193 0.6×	54 0.3×	33	980
Jong Sun Chang South Korea	15	183 0.4×	521 1.3×	284 0.9×	247 0.8×	131 0.6×	18	1.5k

Countries citing papers authored by Runfeng Li

Since Specialization

Citations

This map shows the geographic impact of Runfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runfeng Li more than expected).

Fields of papers citing papers by Runfeng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runfeng Li. The network helps show where Runfeng Li may publish in the future.

Co-authorship network of co-authors of Runfeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Runfeng Li. A scholar is included among the top collaborators of Runfeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runfeng Li. Runfeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Yeqing, Yu‐Tsung Huang, Qiong Lu, et al.. (2025). Yinchenhao Tang exerts an inhibitory effect on the influenza a virus by modulating the JAK/STAT signaling pathway. Journal of Ethnopharmacology. 349. 119886–119886.

Meng, Wei, et al.. (2025). Mechanism of Keke tablets in treating post-infectious cough following influenza A virus infection based on network pharmacology, molecular docking, molecular dynamics and in vivo experiments. International Immunopharmacology. 162. 115123–115123.

Li, Runfeng, et al.. (2024). Enhancing postural balance assessment through neural network-based lower-limb muscle strength evaluation with reduced markers. Computer Methods in Biomechanics & Biomedical Engineering. 29(4). 796–806.

Liu, Chang, et al.. (2024). A mechanistic study of chestnut starch retrogradation and its effects on in vitro starch digestion. International Journal of Biological Macromolecules. 276(Pt 2). 133803–133803. 13 indexed citations

Qin, Shulin, Lichun Ma, Runfeng Li, et al.. (2023). Multifunctional Ca2+ nanomodulators regulate type I interferon pathway to remodel tumor microenvironment for cancer immunotherapy. Chemical Engineering Journal. 477. 147118–147118. 5 indexed citations

Pan, Hudan, Xiaojun Yao, Han Zhang, et al.. (2023). Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice. Phytomedicine. 116. 154858–154858. 23 indexed citations

Wu, Xiao Y., Runfeng Li, Zhengshi Lin, et al.. (2023). Coinfection with influenza virus and non-typeable Haemophilus influenzae aggregates inflammatory lung injury and alters gut microbiota in COPD mice. Frontiers in Microbiology. 14. 1137369–1137369. 11 indexed citations

Zhao, Jin, et al.. (2022). Lianhuaqingwen capsule inhibits non-lethal doses of influenza virus-induced secondary Staphylococcus aureus infection in mice. Journal of Ethnopharmacology. 298. 115653–115653. 15 indexed citations

Liu, Xin, Jing Fu, Ji Yang, et al.. (2021). Linderaggrenolides A–N, Oxygen-Conjugated Sesquiterpenoid Dimers from the Roots of Lindera aggregata. ACS Omega. 6(8). 5898–5909. 15 indexed citations

10.

Li, Runfeng, Xiaobo Zhou, Hongxia Zhou, et al.. (2021). Novel Fatty Acid in Cordyceps Suppresses Influenza A (H1N1) Virus-Induced Proinflammatory Response Through Regulating Innate Signaling Pathways. ACS Omega. 6(2). 1505–1515. 14 indexed citations

11.

Zhao, Jin, et al.. (2021). Chaiqin Qingning Capsule Inhibits Influenza Virus Infection and Inflammation In Vitro and In Vivo. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 7 indexed citations

12.

Hamdoun, Sami, Ruihong Chen, Yuan Qing Qu, et al.. (2021). Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry. Pharmacological Research. 172. 105820–105820. 69 indexed citations

13.

Wu, Xiao Y., Runfeng Li, Yunceng Weng, et al.. (2021). Correlation of adhesion molecules and non-typeable haemophilus influenzae growth in a mice coinfected model of acute inflammation. Microbes and Infection. 23(8). 104839–104839. 6 indexed citations

14.

Zhou, Hongxia, Runfeng Li, Yifeng Wang, et al.. (2020). Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response. Phytomedicine. 77. 153272–153272. 30 indexed citations

15.

Li, Runfeng, Yunlong Hou, Jicheng Huang, et al.. (2020). Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2). Pharmacological Research. 156. 104761–104761. 495 indexed citations breakdown →

16.

Ti, Huihui, Yang Zhou, Xue Liang, et al.. (2019). Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs). Journal of Medicinal Chemistry. 62(13). 5944–5978. 22 indexed citations

17.

Gu, Zhen, Irina A. Leneva, Haiming Jiang, et al.. (2019). The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis. International Immunopharmacology. 68. 58–67. 20 indexed citations

18.

Zhao, Xin, Runfeng Li, Yang Zhou, et al.. (2018). Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses. Journal of Medicinal Chemistry. 61(12). 5187–5198. 27 indexed citations

19.

Li, Runfeng, Mark Zanin, Xueshan Xia, & Zifeng Yang. (2018). The tree shrew as a model for infectious diseases research. Journal of Thoracic Disease. 10(S9). S2272–S2279. 20 indexed citations

20.

Dong, Jianghong, Shengwei Chen, Runfeng Li, et al.. (2015). Imidazole-based pinanamine derivatives: Discovery of dual inhibitors of the wild-type and drug-resistant mutant of the influenza A virus. European Journal of Medicinal Chemistry. 108. 605–615. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact